Takeda Revamp to Cut Costs, Use AI to Incur ¥150 Billion Charge
Takeda Pharmaceutical Co. expects to book about ¥150 billion ($945 million) in restructuring charges for the fiscal year starting next month Japan’s largest drugmaker overhauls its business to cut costs...
By Kanoko Matsuyama · Bloomberg
Takeda Pharmaceutical Co. expects to book about ¥150 billion ($945 million) in restructuring charges for the fiscal year starting next month Japan’s largest drugmaker overhauls its business to cut costs and embrace new technologies to boost efficiency and growth.